INmune Bio, Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.789
+0.009 (0.53%)
Oct 23, 2025, 12:25 PM EDT - Market open
INmune Bio Market Cap
INmune Bio has a market cap or net worth of $47.57 million as of October 23, 2025. Its market cap has decreased by -58.91% in one year.
Market Cap
47.57M
Enterprise Value
14.40M
1-Year Change
-58.91%
Ranking
Category
Stock Price
$1.79
Market Cap Chart
Since February 4, 2019, INmune Bio's market cap has decreased from $77.82M to $47.57M, a decrease of -38.87%. That is a compound annual growth rate of -7.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2025 | 47.32M | -54.30% |
| Dec 31, 2024 | 103.55M | -48.97% |
| Dec 29, 2023 | 202.92M | 78.35% |
| Dec 30, 2022 | 113.78M | -37.49% |
| Dec 31, 2021 | 182.00M | -21.41% |
| Dec 31, 2020 | 231.57M | 270.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 4, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 729.35B |
| Johnson & Johnson | 464.66B |
| AbbVie | 403.98B |
| UnitedHealth Group | 327.39B |
| AstraZeneca | 259.95B |
| Novartis AG | 255.24B |
| Novo Nordisk | 237.27B |
| Abbott Laboratories | 222.69B |